Cutaneous adverse events associated with immune checkpoint blockade: A systematic review and meta-analysis

被引：13
作者：
Han, Yiqun [1 ]
Wang, Jiayu [1 ]
Xu, Binghe [1 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Dept Med Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China
来源：
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2021年 / 163卷
关键词：
Cutaneous toxicity; Immune-related adverse events; Immune checkpoint inhibitors; Meta-analysis; CELL LUNG-CANCER; PHASE-III TRIAL; DOUBLE-BLIND; OPEN-LABEL; STAGE-III; 2ND-LINE THERAPY; TUMOR RESPONSE; PEMBROLIZUMAB; IPILIMUMAB; NIVOLUMAB;
D O I：
10.1016/j.critrevonc.2021.103376
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Dermatological toxicity is the most common immune-related adverse events (irAEs) following immune checkpoint inhibitors (ICIs). A better understanding of this side effect enables early recognition, diagnosis and management in clinical practice. We did a systematic review and meta-analysis of literature published on ClinicalTrials.gov, Pubmed, Embase, and Cochrane Library to assess the differences in cutaneous irAEs among ICIs, the effect from dosage and combined treatment on the incidence, and the predictive values for prognosis. A total of 46 eligible RCTs involving 28,569 patients were included. This study indicates that cutaneous irAEs are dose-independent and agent-specific immune reactions with the highest risk observed in CTLA-4 blockade and might not a surrogate prognostic indicator.
引用
收藏
页数：7
相关论文
共 50 条
  • [1] Association of Immune Checkpoint Inhibitors With Neurologic Adverse Events A Systematic Review and Meta-analysis
    Farooq, Muhammad Zain
    Aqeel, Sheeba Ba
    Lingamaneni, Prasanth
    Pichardo, Rayli Carolina
    Jawed, Aleeza
    Khalid, Saad
    Banskota, Shristi Upadhyay
    Fu, Pingfu
    Mangla, Ankit
    JAMA NETWORK OPEN, 2022, 5 (04)
  • [2] Risk and incidence of fatal adverse events associated with immune checkpoint inhibitors: a systematic review and meta-analysis
    Jiang, Yi
    Zhang, Ning
    Pang, Hailin
    Gao, Xiaobo
    Zhang, Helong
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2019, 15 : 293 - 302
  • [3] Risk of Ophthalmic Adverse Events in Patients Treated with Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis
    Hou, Yan-Li
    Wang, Di-Ya
    Hu, Jie-Xuan
    Tian, Ru-Yue
    Wang, Wei
    Su, Qiang
    Li, Hongyang
    Wang, Yan-Ling
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2022, 30 (06) : 1449 - 1459
  • [4] Immune-related adverse events associated with nab-paclitaxel/paclitaxel combined with immune checkpoint inhibitors: a systematic review and network meta-analysis
    Hao, Wenjing
    Zhang, Jun
    Wang, Yunxia
    Fang, Boyu
    Jin, Shasha
    Yuan, Jing
    Cai, Weimin
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [5] Incidence and Risk of Hematological Adverse Events Associated With Immune Checkpoint Inhibitors: A Systematic Literature Review and Meta-Analysis
    Ohashi, Takuma
    Takase-Minegishi, Kaoru
    Maeda, Ayaka
    Hamada, Naoki
    Yoshimi, Ryusuke
    Kirino, Yohei
    Teranaka, Hiroshi
    Kunimoto, Hiroyoshi
    Hagihara, Maki
    Matsumoto, Kenji
    Namkoong, Ho
    Horita, Nobuyuki
    Nakajima, Hideaki
    JOURNAL OF HEMATOLOGY, 2023, 12 (02) : 66 - 74
  • [6] Are immune-related adverse events associated with the efficacy of immune checkpoint inhibitors in patients with cancer? A systematic review and meta-analysis
    Zhou, Xiaoxiang
    Yao, Zhuoran
    Yang, Huaxia
    Liang, Naixin
    Zhang, Xuan
    Zhang, Fengchun
    BMC MEDICINE, 2020, 18 (01)
  • [7] Cardiac adverse events of immune checkpoint inhibitors in oncology patients: A systematic review and meta-analysis
    Nso, Nso
    Antwi-Amoabeng, Daniel
    Beutler, Bryce D.
    Ulanja, Mark B.
    Ghuman, Jasmine
    Hanfy, Ahmed
    Nimo-Boampong, Joyce
    Atanga, Sirri
    Doshi, Rajkumar
    Enoru, Sostanie
    Gullapalli, Nageshwara
    WORLD JOURNAL OF CARDIOLOGY, 2020, 12 (11): : 584 - 598
  • [8] Risk of Cardiac Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-Analysis
    Hu, Jiexuan
    Tian, Ruyue
    Ma, Yingjie
    Zhen, Hongchao
    Ma, Xiao
    Su, Qiang
    Cao, Bangwei
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [9] Incidence of Cutaneous Immune-Related Adverse Events and Outcomes in Immune Checkpoint Inhibitor-Containing Regimens: A Systematic Review and Meta-Analysis
    Curkovic, Nina B.
    Bai, Kun
    Ye, Fei
    Johnson, Douglas B.
    CANCERS, 2024, 16 (02)
  • [10] Differential Dermatologic Adverse Events Associated With Checkpoint Inhibitor Monotherapy and Combination Therapy: A Meta-Analysis of Randomized Control Trials
    Ge, Yang
    Zhang, Huiyun
    Weygant, Nathaniel
    Yao, Jiannan
    FRONTIERS IN PHARMACOLOGY, 2021, 12
12345